This HTML5 document contains 19 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n8http://www.viropharma.com/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n7http://dbpedia.org/resource/Claude_H.
n4http://dbpedia.org/resource/Exton,
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:ViroPharma
rdfs:comment
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014.
foaf:name
ViroPharma Incorporated
foaf:homepage
n8:
dbpedia-owl:foundationPlace
n4:_Pennsylvania dbpedia:United_States
dbpedia-owl:foundingYear
1994-01-01Z
dbpedia-owl:industry
dbpedia:Pharmaceutical_industry dbpedia:Health_care dbpedia:Biotechnology
dbpedia-owl:keyPerson
dbpedia:Vincent_Milano n7:_Nash
dbpedia-owl:location
dbpedia:United_States n4:_Pennsylvania
dbpedia-owl:netIncome
1.13705E8
dbpedia-owl:numberOfEmployees
232
dbpedia-owl:operatingIncome
8.8145E7
dbpedia-owl:product
dbpedia:Vancomycin
dbpedia-owl:revenue
1.32417E8
dbpedia-owl:type
dbpedia:Public_company